Advertisement
Organisation › Details
Promise Proteomics SAS
PX'Therapeutics is a biopharmaceutical contract research and manufacturing organisation specialising in the development of therapeutic antibodies and recombinant proteins from early research stage up to clinical grade GMP manufacturing. With more than 160 clients in Europe, North America and Japan, PX'Therapeutics has acquired an extensive knowledge in the production of valuable therapeutic candidates. *
Start | 2019-07-01 renamed | |
Group | Aguettant (Group) | |
Predecessor | PX’Therapeutics S.A. | |
Industry | contract manufacturing (biologicals) | |
Person | Rougemond, Eric (Aguettant 201302– CEO) | |
Person 2 | Rousselle, Tristan (Protein’eXpert 200011–201306 CEO + Co-Founder LEFT 6/13 before Genome Express) | |
Region | Grenoble | |
Country | France | |
Street | 7 parvis Louis Néel BHT 52 A, CS 20050 | |
City | 38040 Grenoble cedex 9 | |
Tel | +33-4-3802-3650 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | B: 11 to 50 (2012-10-01) |
Currency | EUR | |
Annual sales | 8,500,000 (revenues (2011) 2011-12-31) | |
* Document for »About Section«: | ||
Record changed: 2024-03-30 |
Advertisement
More documents for Aguettant (Group)
- [1] PX’Therapeutics S.A.. (2/20/19). "Press Release: 2019 – PX’Therapeutics Develops Its Services Offer"....
- [2] PX’Therapeutics S.A.. (1/17/18). "Press Release: PX’Therapeutics and Advaxis to Collaborate for the Process Development of Lm Based Immunotherapies". Grenoble....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top